During the last decade, the pharmaceutical market was filled with cheap medicines produced in India. Today, India is the largest manufacturer of cheap analogues of famous brand drugs that treat erectile dysfunction. Pharmaceutical giants such as Pfizer, Bayer, Eli Lilly have the huge losses due to the fact that there are numerous generic Viagra, Levitra and Cialis in the market. Despite all attempts to restrict access generics for the treatment of erectile dysfunction on the market, corporations did not succeed. Today, many of the generic drug to treat erectile dysfunction, have been certified, some of them have been approved by the FDA and are freely sold in the U.S., Europe, UK, Australia and many other countries around the world. The pharmacies are ready to sell the cheap drugs from Indian manufacturers.
Due to the growing demand for Indian generic drugs to treat erectile dysfunction, major pharmaceutical corporations are trying by all means to restrict access of these drugs on the market. They constantly file lawsuit against competitors with the purpose to ban the production and sale of generic medicines completely. But such actions can trigger not only social but also economic problems for many developing countries.
Every year, India sends to the worldwide market the generic drugs to treat erectile dysfunction, that cost hundreds of millions of dollars. The price of generics can be several times lower than the original brand drugs, although the pharmacological properties of these drugs are absolutely identical.
All Generics for the treatment of erectile dysfunction are based on the active ingredients that the expensive medications have. Analogues are taken as a basis for such ingredients as sildenafil citrate, tadalafil, vardenafil, dapoxetine. Generic to treat erectile dysfunction have low price, due to several factors, one of which is the absence of costs of production and clinical testing of active substance. Pfizer spent tens of millions of dollars and several years For the development, research and marketing strategy for sildenafil citrate. To cover all costs, the company has to maintain a certain pricing policy; as a result, Brand Viagra pills can be costly for men with low income.
Sildenafil citrate is used for the production of Generic Viagra. Sildenafil has been fully studied and Indian producers did not invest million dollars in the development and promotion. By reducing the costs of generic production, the price is more flexible and as a result several times lower than the cost of brand name drugs.
Despite the low cost of Indian generics, most of them are produced by major pharmaceutical companies and meet all requirements of the WHO. As a result, men can use high-quality medicines for the treatment of erectile dysfunction, at lower prices.
In some countries, a ban on the sale of Indian generic drugs to treat erectile dysfunction is already in operation. This means that a significant numbers of men with low income will not be able to buy medicines to enhance potency; as a result, they lose the ability to have a normal sexual activity. This in turn can lead to serious social problems in the long run. Actually the ordinary ban of Indian generic drugs may lead to a reduction in living standards and reducing the birth rates.
Perhaps such drastic measures against Indian generic drug for the treatment of erectile dysfunction can be temporary, until pharmaceutical companies find consensus and will be able to solve the problem by dividing the market into equal parts, to meet the demand of all social groups of people.
Source: www.best-pharma.com
No comments:
Post a Comment